Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma × Control Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 34 Neoplasms 21 Motor Activity 10 Fatigue 7 Colorectal Neoplasms 7 Stomach Neoplasms 6 Pain, Postoperative 6 Lung Neoplasms 6 Pain 5 Anxiety Disorders 5 Polycystic Ovary Syndrome 4 Depression 4 Uterine Cervical Neoplasms 3 Thyroid Neoplasms 3 Stomatitis 3 Sleep Initiation and Maintenance Disorders 3 Malnutrition 3 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Agnosia 3 Vomiting 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Parasomnias 2 Ovarian Neoplasms 2 Nausea 2 Lymphatic Metastasis 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2

Interventions

Cisplatin 17 Gemcitabine 15 pembrolizumab 14 Radiotherapy 13 Paclitaxel 13 Radiotherapy, Intensity-Modulated 12 Carboplatin 10 Cyclophosphamide 9 Cetuximab 8 Magnetic Resonance Spectroscopy 7 Specimen Handling 6 Oxaliplatin 6 Fluorouracil 6 Docetaxel 6 Capecitabine 6 padeliporfin 5 Radiation 5 Irinotecan 5 Drug Therapy 5 poly ICLC 4 fludarabine 4 anlotinib 4 Standard of Care 4 Nivolumab 4 Leucovorin 4 Ipilimumab 4 Celecoxib 4 durvalumab 3 Sunitinib 3 Sorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04104334 2021-10-08

CHIPNOL

Ciusss de L'Est de l'Île de Montréal

Phase NA Terminated

Gastrointestinal

Hyperthermia, Carcinoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡